PNC Financial Services Group’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-165
| Closed | -$2.44K | – | 4986 |
|
|
2024
Q1 | $2.44K | Buy |
165
+157
| +1,963% | +$2.32K | ﹤0.01% | 4152 |
|
|
2023
Q4 | $107 | Buy |
+8
| New | +$107 | ﹤0.01% | 4516 |
|
|
2021
Q2 | – | Sell |
-200
| Closed | -$1K | – | 4398 |
|
|
2021
Q1 | $1K | Buy |
+200
| New | +$1K | ﹤0.01% | 4082 |
|
|
2017
Q1 | – | Sell |
-4,057
| Closed | -$130K | – | 4303 |
|
|
2016
Q4 | $130K | Hold |
4,057
| – | – | ﹤0.01% | 2329 |
|
|
2016
Q3 | $202K | Sell |
4,057
-585
| -13% | -$29.1K | ﹤0.01% | 2091 |
|
|
2016
Q2 | $197K | Sell |
4,642
-26
| -0.6% | -$1.1K | ﹤0.01% | 2101 |
|
|
2016
Q1 | $306K | Buy |
4,668
+3
| +0.1% | +$197 | ﹤0.01% | 1842 |
|
|
2015
Q4 | $291K | Buy |
4,665
+1,195
| +34% | +$74.5K | ﹤0.01% | 1844 |
|
|
2015
Q3 | $233K | Buy |
3,470
+884
| +34% | +$59.4K | ﹤0.01% | 2030 |
|
|
2015
Q2 | $251K | Buy |
2,586
+31
| +1% | +$3.01K | ﹤0.01% | 2076 |
|
|
2015
Q1 | $238K | Buy |
2,555
+2,511
| +5,707% | +$234K | ﹤0.01% | 2110 |
|
|
2014
Q4 | $4K | Buy |
+44
| New | +$4K | ﹤0.01% | 3626 |
|
|
2013
Q4 | – | Sell |
-1,879
| Closed | -$56K | – | 3699 |
|
|
2013
Q3 | $56K | Hold |
1,879
| – | – | ﹤0.01% | 2436 |
|
|
2013
Q2 | $100K | Buy |
+1,879
| New | +$100K | ﹤0.01% | 2124 |
|